# Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)

> **NCT02552862** · PHASE3 · WITHDRAWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau**

## Conditions studied

- Spontaneous Bacterial Peritonitis

## Interventions

- **DRUG:** Vivomixx®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02552862
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No candidates during recruiting time. There were no candidates meeting the inclusion criteria
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02552862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02552862, "Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02552862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*